Intervention Review

Huperzine A for mild cognitive impairment

  1. Jirong Yue1,
  2. Bi Rong Dong1,*,
  3. Xiufang Lin1,
  4. Ming Yang1,
  5. Hong Mei Wu1,
  6. Taixiang Wu2

Editorial Group: Cochrane Dementia and Cognitive Improvement Group

Published Online: 12 DEC 2012

Assessed as up-to-date: 19 JUL 2012

DOI: 10.1002/14651858.CD008827.pub2


How to Cite

Yue J, Dong BR, Lin X, Yang M, Wu HM, Wu T. Huperzine A for mild cognitive impairment. Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD008827. DOI: 10.1002/14651858.CD008827.pub2.

Author Information

  1. 1

    West China Hospital, Sichuan University, Department of Geriatrics, Chengdu, Sichuan, China

  2. 2

    West China Hospital, Sichuan University, Chinese Clinical Trial Registry, Chinese Ethics Committee of Registering Clinical Trials, Chengdu, Sichuan, China

*Bi Rong Dong, Department of Geriatrics, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan, 610041, China. birongdong@163.com.

Publication History

  1. Publication Status: New
  2. Published Online: 12 DEC 2012

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.